SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹61 Cr | ₹52 Cr | ₹23 Cr | ₹19 Cr |
What is the latest Net Current Assets ratio of SHREE GANESH REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹52 Cr |
| Mar2020 | ₹23 Cr |
| Mar2019 | ₹19 Cr |
How is Net Current Assets of SHREE GANESH REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 19.16 | |
| Mar2024 | ₹52 Cr | 119.82 | |
| Mar2020 | ₹23 Cr | 23.20 | |
| Mar2019 | ₹19 Cr | - | |
Compare Net Current Assets of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹899.8 Cr | 23.6% | 23.7% | -4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 23.6% |
23.7% |
-4.6% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses